5 research outputs found
Π€Π°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΡΠ΅ΡΠ΄ΡΠ° ΠΈ Π²ΠΎΠ·ΡΠ°ΡΡ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°ΠΌΠΈ ΠΏΡΠΈ ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠΌ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠΌ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ
Highlights. Patients with coronary artery disease and age-related disorders (sarcopenia, osteopenic syndrome, osteosarcopenia) who underwent elective on-pump coronary artery bypass grafting are at higher risk of developing cardiovascular complications, non-infectious complications, and death.Musculoskeletal disorders (sarcopenia, osteopenic syndrome, osteosarcopenia) in combination with traditional predictors (age, diabetes mellitus, prior myocardial infarction and stroke, cancer) are risk factors for unfavorable prognosis of postoperative period of coronary artery bypass grafting.Β Aim. To assess risk factors for unfavorable prognosis in patients with coronary artery disease (CAD) undergoing elective on-pump coronary artery bypass grafting, taking into account age-related disorders (sarcopenia, osteopenic syndrome, osteosarcopenia).Methods. This single-center study included 387 CAD patients admitted for elective coronary artery bypass grafting. Taking into account the diagnosed age-related disorders, four groups of patients were formed. The first group consisted of 52 (13.4%) patients with sarcopenia, the second group was comprised of 28 (7.2%) patients with osteopenia (osteopenia/osteoporosis), the third group included 25 (6.5%) patients with osteosarcopenia, and the fourth group consisted of 282 (72.9%) participants with coronary artery disease and without musculoskeletal disorders (MSD). Risk factors for a composite endpoint (myocardial infarction, stroke, paroxysmal atrial fibrillation, cardiac rhythm disturbances) and death, and noninfectious complications (resternotomy for bleeding, pneumothorax aspiration and thoracentesis) were assessed.Results. The composite endpoint occurred more frequently in patients with osteopenia (group I β 9.6%, group II β 32.1%, group III β 12%, group IV β 12.8%; p = 0.029), and non-infectious complications occurred more frequently in patients with sarcopenia and osteosarcopenia (group I β 17.3%, group II β 7.1%, group III β 12%, group IV β 5.3%; p = 0.002). MSD were associated with the risk of composite endpoint (odds ratio (OR) 1.73, p = 0.035), and osteopenia increased it three-fold (OR 3.01, p = 0.046). Moreover, MSD were associated with higher risk of non-infectious complications (OR 1.71, p = 0.026), especially in patients with sarcopenia (OR 2.02, p = 0.034). The assessment of risk factors for unfavorable prognosis highlighted the presence of osteopenic syndrome (100 CU), prior stroke (88 CU) and myocardial infarction (85 CU). The risk of non-infectious complications was associated with prior ischemic events (ranking level for myocardial infarction β 100 CU, stroke β 75 CU), and MSD (89 CU) and its types (osteosarcopenia β 77 CU, osteopenia β 69 CU, sarcopenia β 52 CU).Conclusion. Age-related disorders in combination with MSD increase the risk of a composite endpoint and non-infectious complications by one to three times.ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΡ. ΠΠ°ΡΠΈΠ΅Π½ΡΡ Ρ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΡΠ΅ΡΠ΄ΡΠ° ΠΈ Π²ΠΎΠ·ΡΠ°ΡΡ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌΠΈ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ°ΠΌΠΈ (ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ, ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ, ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ), ΠΏΠ΅ΡΠ΅Π½Π΅ΡΡΠΈΠ΅ ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠ΅ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ΅ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ, Π² Π±ΠΎΠ»ΡΡΠ΅ΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΏΠΎΠ΄Π²Π΅ΡΠΆΠ΅Π½Ρ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎΡΠΎΡΡΠ΄ΠΈΡΡΡΠΌ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌ ΠΈ ΡΠΌΠ΅ΡΡΠΈ, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠΌ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡΠΌ, ΡΠ²ΡΠ·Π°Π½Π½ΡΠΌ Ρ Ρ
ΠΈΡΡΡΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ΠΌ.ΠΠ°ΡΡΠ΄Ρ Ρ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΠΌΠΈ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΎΡΠ°ΠΌΠΈ (Π²ΠΎΠ·ΡΠ°ΡΡ, ΡΠ°Ρ
Π°ΡΠ½ΡΠΉ Π΄ΠΈΠ°Π±Π΅Ρ, ΡΠ°Π½Π΅Π΅ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ΅Π½Π½ΡΠΉ ΠΈΠ½ΡΠ°ΡΠΊΡ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° ΠΈ ΠΈΠ½ΡΡΠ»ΡΡ, ΠΎΠ½ΠΊΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ) ΠΈΡΡ
ΠΎΠ΄Π½ΠΎΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠΎΡΡΠ½ΠΎ-ΠΌΡΡΠ΅ΡΠ½ΠΎΠΉ ΡΡΠ½ΠΊΡΠΈΠΈ ΠΈ Π΅Π³ΠΎ Π²Π°ΡΠΈΠ°Π½ΡΡ (ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ, ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ, ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ) ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΊ ΡΠ°ΠΊΡΠΎΡΠ°ΠΌ Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΡΠ΅ΡΠ΅Π½ΠΈΡ Π³ΠΎΡΠΏΠΈΡΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΠ΅ΡΠΈΠΎΠ΄Π° ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ.Π¦Π΅Π»Ρ. ΠΡΠ΅Π½ΠΈΡΡ ΡΠ°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° Π½Π΅Π±Π»Π°Π³ΠΎΠΏΡΠΈΡΡΠ½ΠΎΠ³ΠΎ ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΡΠ΅ΡΠ΄ΡΠ° (ΠΠΠ‘) Ρ ΡΡΠ΅ΡΠΎΠΌ Π²ΠΎΠ·ΡΠ°ΡΡ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠ² (ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ, ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΡΠΈΠ½Π΄ΡΠΎΠΌ, ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ), Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΡΡ
Π½Π° ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠ΅ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ΅ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΈΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ ΠΊΡΠΎΠ²ΠΎΠΎΠ±ΡΠ°ΡΠ΅Π½ΠΈΡ.ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ΄Π½ΠΎΡΠ΅Π½ΡΡΠΎΠ²ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ 387 Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΠΠ‘, ΠΏΠΎΡΡΡΠΏΠΈΠ²ΡΠΈΡ
Π΄Π»Ρ ΠΏΠ»Π°Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΊΠΎΡΠΎΠ½Π°ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ½ΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ. Π‘ ΡΡΠ΅ΡΠΎΠΌ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
Π²ΠΎΠ·ΡΠ°ΡΡ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
ΡΠΈΠ½Π΄ΡΠΎΠΌΠΎΠ² ΡΡΠΎΡΠΌΠΈΡΠΎΠ²Π°Π½Ρ ΡΠ΅ΡΡΡΠ΅ Π³ΡΡΠΏΠΏΡ. ΠΠ΅ΡΠ²Π°Ρ Π³ΡΡΠΏΠΏΠ° β 52 (13,4%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠ° Ρ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ, Π²ΡΠΎΡΠ°Ρ β 28 (7,2%) Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ (ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡ/ΠΎΡΡΠ΅ΠΎΠΏΠΎΡΠΎΠ·), ΡΡΠ΅ΡΡΡ β 25 (6,5%) ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ, ΡΠ΅ΡΠ²Π΅ΡΡΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 282 (72,9%) ΡΡΠ°ΡΡΠ½ΠΈΠΊΠ° Ρ ΠΠΠ‘ Π±Π΅Π· Π½Π°ΡΡΡΠ΅Π½ΠΈΠΉ ΠΊΠΎΡΡΠ½ΠΎ-ΠΌΡΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°ΡΡΡΠ° (ΠΠΠ‘). ΠΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΡΠ°ΠΊΡΠΎΡΡ ΡΠΈΡΠΊΠ° ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΠΎΡΠΊΠΈ, ΠΎΠ±ΡΠ΅Π΄ΠΈΠ½ΡΠ²ΡΠ΅ΠΉ ΡΠ΅ΡΠ΄Π΅ΡΠ½ΠΎ-ΡΠΎΡΡΠ΄ΠΈΡΡΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ (ΠΈΠ½ΡΠ°ΡΠΊΡ ΠΌΠΈΠΎΠΊΠ°ΡΠ΄Π° (ΠΠ), ΠΈΠ½ΡΡΠ»ΡΡ, ΠΏΠ°ΡΠΎΠΊΡΠΈΠ·ΠΌ ΡΠΈΠ±ΡΠΈΠ»Π»ΡΡΠΈΠΈ ΠΏΡΠ΅Π΄ΡΠ΅ΡΠ΄ΠΈΠΉ, Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΡΡΠΈ) ΠΈ ΡΠΌΠ΅ΡΡΡ, Π° ΡΠ°ΠΊΠΆΠ΅ Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ (Π³Π΅ΠΌΠΎΡΡΠ°Π³ΠΈΡΠ΅ΡΠΊΠΎΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠ΅, ΠΏΠΎΡΡΠ΅Π±ΠΎΠ²Π°Π²ΡΠ΅Π΅ ΡΠ΅ΡΡΠ΅ΡΠ½ΠΎΡΠΎΠΌΠΈΠΈ, ΠΏΠ½Π΅Π²ΠΌΠΎ- ΠΈ Π³ΠΈΠ΄ΡΠΎΡΠΎΡΠ°ΠΊΡ Ρ ΠΏΠ»Π΅Π²ΡΠ°Π»ΡΠ½ΠΎΠΉ ΠΏΡΠ½ΠΊΡΠΈΠ΅ΠΉ).Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ. ΠΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΠΊΠΎΠ½Π΅ΡΠ½ΡΡ ΡΠΎΡΠΊΡ ΡΠ°ΡΠ΅ ΡΠ΅Π³ΠΈΡΡΡΠΈΡΠΎΠ²Π°Π»ΠΈ ΡΡΠ΅Π΄ΠΈ Π±ΠΎΠ»ΡΠ½ΡΡ
ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ (I Π³ΡΡΠΏΠΏΠ° β 9,6%, II Π³ΡΡΠΏΠΏΠ° β 32,1%, III Π³ΡΡΠΏΠΏΠ° β 12%, IV Π³ΡΡΠΏΠΏΠ° β 12,8%; Ρ = 0,029), Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ β Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ ΠΈ ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΠ΅ΠΉ (I Π³ΡΡΠΏΠΏΠ° β 17,3%, II Π³ΡΡΠΏΠΏΠ° β 7,1%, III Π³ΡΡΠΏΠΏΠ° β 12%, IV Π³ΡΡΠΏΠΏΠ° β 5,3%; Ρ = 0,002). ΠΠ°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΠΠ‘ ΡΠΎΠΏΡΡΠΆΠ΅Π½ΠΎ Ρ ΡΠΈΡΠΊΠΎΠΌ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΠΎΡΠΊΠΈ (ΠΎΡΠ½ΠΎΡΠ΅Π½ΠΈΠ΅ ΡΠ°Π½ΡΠΎΠ² (ΠΠ¨) 1,73, Ρ = 0,035), ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½Π°Ρ ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡ ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°Π»Π° ΡΡΠΎΡ ΡΠΈΡΠΊ Π² ΡΡΠΈ ΡΠ°Π·Π° (ΠΠ¨ 3,01, Ρ = 0,046). Π’Π°ΠΊΠΆΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΠΠ‘ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½ΠΎ Ρ ΡΠΎΡΡΠΎΠΌ Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ (ΠΠ¨ 1,71, Ρ = 0,026), Π² ΡΠ°ΡΡΠ½ΠΎΡΡΠΈ ΠΏΡΠΈ ΠΈΠ·ΠΎΠ»ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΠΈ (ΠΠ¨ 2,02, Ρ = 0,034). Π Π°ΡΡΠ΅Ρ ΡΠ°Π½Π³ΠΎΠ² Π·Π½Π°ΡΠΈΠΌΠΎΡΡΠΈ Π²ΠΊΠ»Π°Π΄Π° ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π² ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΠΎΡΠΊΠΈ ΠΏΠΎΠΊΠ°Π·Π°Π» Π½Π°Π»ΠΈΡΠΈΠ΅ ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠΈΠ½Π΄ΡΠΎΠΌΠ° (100 Ρ.Π΅.), ΡΠ°Π½Π΅Π΅ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ΅Π½Π½ΠΎΠ³ΠΎ ΠΈΠ½ΡΡΠ»ΡΡΠ° (88 Ρ.Π΅.) ΠΈ ΠΠ (85 Ρ.Π΅.). Π ΠΈΡΠΊ Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½ Ρ ΠΏΠ΅ΡΠ΅Π½Π΅ΡΠ΅Π½Π½ΡΠΌΠΈ ΡΠ°Π½Π΅Π΅ ΠΈΡΠ΅ΠΌΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠΎΠ±ΡΡΠΈΡΠΌΠΈ (ΡΡΠΎΠ²Π΅Π½Ρ ΡΠ°Π½Π³ΠΎΠ² Π΄Π»Ρ ΠΠ β 100 Ρ.Π΅., Π΄Π»Ρ ΠΈΠ½ΡΡΠ»ΡΡΠ° β 75 Ρ.Π΅.), Π° ΡΠ°ΠΊΠΆΠ΅ Ρ Π½Π°ΡΡΡΠ΅Π½ΠΈΡΠΌΠΈ ΠΠΠ‘ (89 Ρ.Π΅.) ΠΈ Π΅Π³ΠΎ Π²Π°ΡΠΈΠ°Π½ΡΠ°ΠΌΠΈ (ΠΎΡΡΠ΅ΠΎΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ β 77 Ρ.Π΅., ΠΎΡΡΠ΅ΠΎΠΏΠ΅Π½ΠΈΡ β 69 Ρ.Π΅., ΡΠ°ΡΠΊΠΎΠΏΠ΅Π½ΠΈΡ β 52 Ρ.Π΅.).ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅. ΠΠΎΠ·ΡΠ°ΡΡ-Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ, ΡΠΎΠΏΡΠΎΠ²ΠΎΠΆΠ΄Π°ΡΡΠΈΠ΅ Π½Π°ΡΡΡΠ΅Π½ΠΈΠ΅ ΠΠΠ‘, ΡΠ²Π΅Π»ΠΈΡΠΈΠ²Π°ΡΡ ΡΠΈΡΠΊ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΊΠΎΠΌΠ±ΠΈΠ½ΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΉ ΠΊΠΎΠ½Π΅ΡΠ½ΠΎΠΉ ΡΠΎΡΠΊΠΈ ΠΈ Π½Π΅ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ
ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ Π² 1,7β3,1 ΡΠ°Π·Π°
CHILDRENβS BILINGUALISM. PROBLEMS IN NATURAL LEARNING RUSSIAN AND BULGARIAN LANGUAGES
The article deals with the problem of childrenβs bilingualism whose first language is Bulgarian, and the second is Russian. In polylingual Transnistrian region bilingual children meet some difficulties in their language assimilation (in this case, we mean Russian and Bulgarian languages). These difficulties are: the effect of Parkansky dialect on Bulgarian literary language; errors in spelling, in pronunciation of certain words and expressions. On the other hand, as the language of communication in family continues to be Bulgarian, Russian language skills are limited to everyday speech.Our goal is to understand the mechanism of childrenβs bilingualism developing. We would like to find out, what are the ways and the social causes of bilingualism. This research is based on speech records (bilingual children aged from 3 to 10 ages). As a result, we offer exemplary exercises for working with bilingual children. Finally, weβve discussed the pros and cons of childrenβs bilingualism in polylingual Transnistrian society
Radiology methods of the sarcopenia diagnosis
One of the processes that accompany the aging of the body and the decline in the quality of life of older people is sarcopenia or loss of muscle tissue and the associated restriction of mobility. The identification of this condition in patients at the stage when there is only an initial decrease in muscle mass without a decrease in muscle strength is of great importance for determining the cause of the disease and the timely start of treatment. This review describes the capabilities of the methods of radiation diagnosis in assessing the quantity and quality of muscle tissue and their shortcomings from the standpoint of verification and dynamic observation of sarcopenia. The lack of a unified standard for the instrumental diagnosis of this pathology and the alertness of specialists regarding sarcopenia during routine examination is one of the main reasons for the insufficient detection of muscle loss in the cohort of elderly patients. This review is of interest to a wide range of clinical physicians and radiologists, who are found in their practice with patients of older age groups
Prevalence of Musculoskeletal Disorders in Patients with Coronary Artery Disease
Aim. To study the prevalence of musculoskeletal disorders in patients with stable coronary artery disease (CAD).Material and methods. Patients with stable CAD (n=387) were included in the study. The subjects were admitted to the hospital for planned myocardial revascularization (ages of 50-82). The median age was 65 [59;69] years. Most of the sample consisted of males - 283 (73.1%). 323 (83.5%) patients had arterial hypertension (AH), 57.1% - history of myocardial infarction, and a quarter of the patients had type 2 diabetes mellitus (DM). The study of musculoskeletal system included the identification of sarcopenia in accordance with The European Working Group on Sarcopenia in Older People (EWGSOP, 2019); verification of osteopenia/osteoporosis according to the WHO criteria (2008); diagnosing osteosarcopenia in case of sarcopenia and osteopenia/osteoporosis coexistence.Results. At the initial screening of sarcopenia in accordance with EWGSOP, clinical signs (according to the Strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire) were detected in 41.3% of cases, but further examination (dynamometry, quantitative assessment of skeletal muscle) confirmed this diagnosis only in 19.9% of patients with CAD. Among the examined patients with CAD a low T-score according to DEXA was found in 53 (13.7%) of cases, and osteopenia was diagnosed 10 times more often than osteoporosis (90.6% vs. 9.4%). Furthermore, due to combination of low bone density (osteopenia/osteoporosis) and reduced muscle mass and strength (sarcopenia), osteosarcopenia was verified in one patient. Thus, the study revealed the prevalence of particular types of musculoskeletal disorders in 105 (27.1%) patients with stable CAD. The most common type of musculoskeletal disorder was sarcopenia - 52 cases (13.4%); osteopenia/osteoporosis was detected in 28 patients (7.2%), osteosarcopenia in 25 (6.5%). The most pronounced clinical manifestation of sarcopenia and osteopenia/osteoporosis, reflected by a higher score on the SARC-F questionnaire, low handgrip strength, small area of muscle tissue, low musculoskeletal index, as well as low values of bone mineral density, were observed in patients with osteosarcopenia. Patients with osteopenia/osteoporosis did not differ significantly from patients without musculoskeletal conditions in most parameters, with the exception of the T-score, the average SARC-F score, and muscle strength in men. The conducted correlation analysis revealed not only the relationship between the parameters of musculoskeletal function, but also their association with age, duration of AH, CAD, and type 2 DM.Conclusion. Several types of musculoskeletal disorders were found in a third of patients with CAD. Sarcopenia was revealed to be the most frequent type of musculoskeletal disorder